In order to ensure that you continue to receive information that is of interest from PharmaVentures help us by subscribing. Thank you for your co-operation. Welcome to the first edition of Drug Delivery E-News This new monthly E-News bulletin has been designed to keep you up-to-date with all the latest deal making developments within the drug delivery arena. Developed alongside the Drug Delivery Report, this monthly newsletter contains key facts and trends, company profiles and opportunities within the drug delivery market. PharmaVentures Intelligence publishes the Drug Delivery Report - providing pharmaceutical and biotechnology companies worldwide with essential business intelligence and management information relating to deal making and alliances. Part of PharmaVentures, which comprises two specialist areas - PharmaVentures Consulting and PharmaVentures Intelligence, we work with our clients to drive greater value from their deals. See how we could help your organisation Market News and Trends In February, PharmaDeals® Agreements recorded 16 drug delivery deals. Three deals involved the acquisition of an organisation or specific assets, the acquiring companies being LAB International, Cytyc Corp. and Archimedes Pharma. Read more... Featured Article Osmotic Drug Delivery Systems for Poorly Soluble Drugs Over the past decade the pharmaceutical industry has faced continuing challenges in bringing NCEs to the market. In addition, the cost of developing NCE's keeps rising! A valuable role is being played by drug delivery systems in providing optimised products for existing drugs in terms of either enhanced or improved presentation of the drug to the systemic circulation and these are discussed by Dr Padmanabh Bhatt of Shire Laboratories. Read more... Company Profiles ALZA Corporation, Aradigm Corporation, Cardinal Health, Nektar Therapeutics Drug Delivery Opportunities See current drug delivery opportunities. Alternatively request a password to enable you to enter your opportunity online. New Spring/Summer 2005 Drug Delivery Report! Make sure you profile your company in the next edition of the Drug Delivery Companies Report. Pharmaceutical and biotechnology executives regularly refer to this report throughout the year. If you are looking to complete a deal in 2005, then advertising in the Drug Delivery Companies Report is a must. Read more... Apply to receive your copy of the next edition of the Drug Delivery Report
Drug Delivery E-News is produced by PharmaVentures Intelligence, part of PharmaVentures - a leading results driven organisation assisting pharmaceutical and biotechnology companies worldwide in all aspects of deal making. Comprising two specialist areas - PharmaVentures Consulting and PharmaVentures Intelligence, we work with clients to drive greater value from their deals. If you do not wish to receive E-News in future, please email ddcr@pharmamail.biz with the words UNSUBSCRIBE as the subject. If you do not wish to receive other e-mail communications from PharmaVentures or selected third parties, please e-mail ddcr@pharmamail.biz with REMOVE as the subject. For more details contact Mel Hemamda, Product Manager, PharmaVentures Ltd, Magdalen Centre, Oxford Science Park, Oxford OX4 4GA, UK. Tel: +44 (0) 1865 784 177 Fax: +44 (0) 1865 784 178 E-mail enquiries@ddcr.com www.ddcr.com